Trending Now
Halozyme’s ENHANZE® (HALO) Technology Empowers OCREVUS ZUNOVO™: A New Era in...
Subcutaneous Convenience, Uncompromised Efficacy
Halozyme Therapeutics (NASDAQ: HALO), a leader in innovative drug delivery solutions, recently announced a significant...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapy treatments, is at...
MAKE IT MODERN
LATEST REVIEWS
Pot Stock Outperformance and How to Play It (GRWG, MEDH, TLRY)
The monster combination of Aphria and Tilray is a loadstone that has sparked a faith-based move by investors into the cannabis space...
MAKE IT MODERN
PERFORMANCE TRAINING
Approval Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine In Teenagers Delayed Because Of Myocarditis Risk
The US Food and Drug Administration is delaying approval of Moderna Inc.'s (NASDAQ: MRNA) Covid-19 vaccination for adolescents in order to see if the...
Corcept Therapeutics (NASDAQ:CORT) Commences Enrolment In GRATITUDE II Trial For Miricorilant On Treatment of...
Corcept Therapeutics Incorporated (NASDAQ:CORT) has enrolled the first subject in its GRATITUDE II Phase 2 double-blind, randomized, placebo-controlled study of miricorilant in obese patients...
Cxapp Inc (CXAI) looks to draw retail traders and shorts
Cxapp Inc (NASDAQ: CXAI) recently experienced a significant price increase of 94.25%, with the stock's price rising from $13.85 to $20.57 (+$6.72)....
The Health Food Space Keeps Roaring (MED, SBEV, WW)
The functional foods market saw sales top $267 billion in February of this year on a global basis, with sales in the US reaching...
Ovid Therapeutics Inc (NASDAQ:OVID) Discloses Findings From Its ARCADE and ENDYMION Studies Of Soticlestat
Ovid Therapeutics Inc (NASDAQ:OVID) recently announced the results of its ARCADE and ENDYMION studies evaluating its pipeline drug soticlestat as a potential therapy for...
MAKE IT MODERN
